COMMUNIQUÉS West-GlobeNewswire

PotNetwork Holding's Diamond CBD Scores Over $300,000 in Sales at the 38th Las Vegas CHAMPS Show
23/07/2018
The Company Continues Record Breaking Trend, Having Showcased Growing Product line to Vendors at the World’s Most Trusted Counter-Culture Trade Show FT LAUDERDALE, Fla., July 23, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE [...]
Transactions under Novozymes’ stock buyback program
23/07/2018
Please read the full announcement in the attached PDF Attachment 2018_44_Stock_Buybackprogram_EN
Novo Nordisk A/S: Share repurchase programme
23/07/2018
Bagsværd, Denmark, 23 July 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]
Immunicum AB (publ) Announces Protocol Approval by the FDA Enabling the Initiation of Expanded Multi-indication Phase Ib/II Combination Trial
23/07/2018
Press Release 23 July 2018 Immunicum AB (publ) Announces Protocol Approval by the FDA Enabling the Initiation of Expanded Multi-indication Phase Ib/II Combination Trial Immunicum AB (publ; IMMU.ST) announced today that [...]
Shire plc : Notice of Results
23/07/2018
Shire to announce second quarter 2018 results Dublin, Ireland - July 23, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG), will announce second quarter 2018 earnings on Tuesday July 31, 2018. Results press release will be [...]
Chi-Med Initiates a Phase Ib/II Proof-of-Concept Trial of Sulfatinib in Pancreatic Neuroendocrine Tumors and Biliary Tract Cancer in the United States
23/07/2018
LONDON, July 23, 2018 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“ Chi-Med ”) (AIM:HCM) (Nasdaq:HCM) has initiated a Phase Ib/II proof-of-concept study of sulfatinib in pancreatic neuroendocrine tumors (“NET [...]
Novartis renews drug donation of Egaten® (triclabendazole) until 2022, reaffirming its commitment to the fight against liver fluke
23/07/2018
Novartis extends agreement with the WHO for the donation of Egaten ® for the treatment of liver fluke, a neglected tropical disease, also known as fascioliasis, that infects more than 2.4 million people globally[1] [...]
MDxHealth (R): Medicare Establishes Final Positive Local Coverage Determination for Use of ConfirmMDx for Prostate Cancer
23/07/2018
NEWS RELEASE Providing Nationwide Coverage for Medicare Patients IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, July 23, 2018 - MDxHealth SA (Euronext: MDXH.BR), today announced that Palmetto GBA, a Medicare [...]
MDxHealth (R) :
23/07/2018
MDxHealth (R): Medicare Establishes Final Positive Local Coverage Determination for Use of ConfirmMDx for Prostate Cancer
23/07/2018
NEWS RELEASE Providing Nationwide Coverage for Medicare Patients IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, July 23, 2018 - MDxHealth SA (Euronext: MDXH.BR), today announced that Palmetto GBA, a Medicare [...]
MDxHealth (R) :
23/07/2018
MDxHealth (R): Medicare Establishes Final Positive Local Coverage Determination for Use of ConfirmMDx for Prostate Cancer
23/07/2018
NEWS RELEASE Providing Nationwide Coverage for Medicare Patients IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, July 23, 2018 - MDxHealth SA (Euronext: MDXH.BR), today announced that Palmetto GBA, a Medicare [...]
MDxHealth (R) :
23/07/2018
MDxHealth (R) : MDxHealth reçoit une détermination de couverture locale finale positive de la part de Medicare pour l'utilisation de ConfirmMDx for Prostate Cancer
23/07/2018
Assurer une couverture à l'échelle nationale pour les patients Medicare IRVINE, CA, et HERSTAL, BELGIQUE - 07h00 CEST, 23 juillet 2018 - MDxHealth SA (Euronext : MDXH.BR), a annoncé aujourd'hui que Palmetto GBA, un sous [...]
BeiGene Announces Preliminary Topline Results of Pivotal Trial in China for Anti-PD-1 Antibody Tislelizumab in Hodgkin’s Lymphoma
22/07/2018
BEIJING, China and CAMBRIDGE, Mass., July 22, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted [...]
BeiGene Announces Plan to Pursue Accelerated Approval in the U.S. of BTK Inhibitor Zanubrutinib in Waldenström Macroglobulinemia (WM)
22/07/2018
Fast Track Designation Granted by U.S. FDA Enrollment Complete in Global Phase 3 Clinical Trial in WM CAMBRIDGE, Mass. and BEIJING, China, July 22, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial- [...]
PotNetwork Holdings, Inc. Withdraws Form 10 due to Unrelated PCAOB Action Against Its Auditor – Refiling Planned
22/07/2018
FT LAUDERDALE, Fla., July 22, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holdings, Inc. (OTC Pink:POTN) announced today that the Company on July 20 th filed a request with the Securities and Exchange [...]
Arcturus Therapeutics Announces Annual and Extraordinary General Meeting of Shareholders to Be Held on August 24, 2018
20/07/2018
SAN DIEGO, July 20, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (“ Arcturus ” or the “ Company ”) (NASDAQ:ARCT), an RNA medicines company, today announced that it will hold an Annual and Extraordinary General [...]
Digirad Corporation to Release 2018 Second Quarter Financial Results on August 2, 2018
20/07/2018
Conference Call and Webcast Set for 11:00 a.m. EDT SUWANEE, Ga., July 20, 2018 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ:DRAD) will release financial results for its second quarter ended June 30, 2018, before the [...]

Pages